Financial Instruments - Schedule of Effect of Designated Derivative Financial Instruments on Consolidated Financial Statements (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]
(Loss) gain recognized in other comprehensive income (OCI)	$ (18)	$ 81	$ 52
Sales	13,118	12,588	14,189
Cost of sales	8,842	8,657	9,683
Other (expense) income, net	(123)	56	285
Gain (loss) reclassified from accumulated OCI into income	506	581	1,316
Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Sales			52
Cost of sales	47	49	32
Other (expense) income, net	(1)	(3)	(3)
Gain (loss) reclassified from accumulated OCI into income	46	46	81
Foreign exchange contracts
Derivative Instruments, Gain (Loss) [Line Items]
(Loss) gain recognized in other comprehensive income (OCI)	$ (18)	$ 81	$ 52